| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |